Skip to Content

Clinical Trial Details

A Randomized, Double-blind, Placebo-controlled Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared with Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-refractory Metastatic Colorectal Cancer

IRB Protocol Number
ACCRU RU021302I

Clinical Trial Categories

  • Colorectal Cancer
Contact
Barbara Beauchemin, RN, BSN at 603-224-2556

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000